Pipeline analysis

• Insights

  Eli Lilly Pipeline Analysis: Gene Therapy Products Accounts for 1/3, What Diseases Are Targeted?

  DrugTimes will present more reports on CGT. Please stay tuned

  2024年8月20日

  3190